Back to search

Peptide record

TPDB13657

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13657
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia AFP-GFuse Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 33-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
VVCACRRALCLPRERRAGFCRIRGRIHPLCCRR
Physicochemical Analysis
C161H283N65O36S6
NDQKMSTWY
R
3897.79
11.80
11
1
11
+9
6.76
-0.112
85.76
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
375
9.62
6
Residue Composition
number
3
A
10
R
0
N
0
D
6
C
1
E
0
Q
2
G
1
H
2
I
3
L
0
K
0
M
1
F
2
P
0
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 3 R: 10 N: 0 D: 0 C: 6 E: 1 Q: 0 G: 2 H: 1 I: 2 L: 3 K: 0 M: 0 F: 1 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
33
C161H283N65O36S6
3897.79
11.80
+9
6.76
-0.112
Evidence Records 8 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.93 µg/mL

Target

C. neofonnans ATCC52817

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
on >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in d
Evidence 2 Activity

Activity

MIC
Antibacterial
3.75 µg/mL

Target

C. neofonnans ATCC 36556 and ATCC 52816

Source & Reference

dbAMP DRAMP

Other

(reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in directly neutralizing herpes simplex virus type I (HSV-1).
Evidence 3 Activity

Activity

MIC
Antifungal
0.93 µg/mL

Target

C. neofonnans ATCC52817

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
on >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in d
Evidence 4 Activity

Activity

MIC
Antifungal
3.75 µg/mL

Target

C. neofonnans ATCC 36556 and ATCC 52816

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in directly neutralizing herpes simplex virus type I (HSV-1).
Evidence 5 Activity

Activity

MIC
Antiparasitic
0.93 µg/mL

Target

C. neofonnans ATCC52817

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
on >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in d
Evidence 6 Activity

Activity

MIC
Antiparasitic
3.75 µg/mL

Target

C. neofonnans ATCC 36556 and ATCC 52816

Source & Reference

dbAMP 3.0 DRAMP

Other

(reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in directly neutralizing herpes simplex virus type I (HSV-1).
Evidence 7 Activity

Activity

MIC
Antiviral
0.93 µg/mL

Target

C. neofonnans ATCC52817

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
on >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in d
Evidence 8 Activity

Activity

MIC
Antiviral
3.75 µg/mL

Target

C. neofonnans ATCC 36556 and ATCC 52816

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(reduction 0.1 log). Fungi: Also, active against C. neofonnans ATCC52817 (MIC 0.93ug/ml), C. neofonnans ATCC 36556 and ATCC 52816 (MIC 3.75ug/ml). Viruses: NP-1 is effective in directly neutralizing herpes simplex virus type I (HSV-1).